SG166681A1 - Crystalline n-formyl hydroxylamine compounds - Google Patents
Crystalline n-formyl hydroxylamine compoundsInfo
- Publication number
- SG166681A1 SG166681A1 SG200801365-8A SG2008013658A SG166681A1 SG 166681 A1 SG166681 A1 SG 166681A1 SG 2008013658 A SG2008013658 A SG 2008013658A SG 166681 A1 SG166681 A1 SG 166681A1
- Authority
- SG
- Singapore
- Prior art keywords
- crystalline
- 7alkanes
- hydroxylamine compounds
- formyl hydroxylamine
- compounds
- Prior art date
Links
- KDGKTJGPFXIBEB-UHFFFAOYSA-N n-hydroxyformamide Chemical class ONC=O KDGKTJGPFXIBEB-UHFFFAOYSA-N 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45972603P | 2003-04-02 | 2003-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG166681A1 true SG166681A1 (en) | 2010-12-29 |
Family
ID=33131903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200801365-8A SG166681A1 (en) | 2003-04-02 | 2004-04-01 | Crystalline n-formyl hydroxylamine compounds |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070135353A1 (https=) |
| EP (1) | EP1613305A1 (https=) |
| JP (1) | JP2006522054A (https=) |
| KR (1) | KR20060002915A (https=) |
| CN (1) | CN1764450A (https=) |
| AR (1) | AR043804A1 (https=) |
| AU (1) | AU2004226815B2 (https=) |
| BR (1) | BRPI0409009A (https=) |
| CA (1) | CA2520682A1 (https=) |
| CL (1) | CL2004000705A1 (https=) |
| CO (1) | CO5630028A2 (https=) |
| EC (1) | ECSP056043A (https=) |
| IS (1) | IS8093A (https=) |
| MA (1) | MA27763A1 (https=) |
| MX (1) | MXPA05010610A (https=) |
| MY (1) | MY136854A (https=) |
| NO (1) | NO20055097L (https=) |
| NZ (1) | NZ542432A (https=) |
| PE (1) | PE20050392A1 (https=) |
| RU (1) | RU2005133660A (https=) |
| SG (1) | SG166681A1 (https=) |
| TN (1) | TNSN05248A1 (https=) |
| TW (1) | TW200427458A (https=) |
| WO (1) | WO2004087133A1 (https=) |
| ZA (1) | ZA200507179B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1406893B1 (en) | 2001-06-15 | 2007-04-18 | Vicuron Pharmaceuticals, Inc. | Pyrrolidine bicyclic compounds |
| ATE417826T1 (de) | 2002-09-19 | 2009-01-15 | Novartis Pharma Gmbh | Verfahren zur herstellung von zwischenprodukten |
| MXPA05008842A (es) | 2003-02-21 | 2005-10-05 | Novartis Ag | Proceso quimico. |
| GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
| JP7001898B2 (ja) * | 2016-05-11 | 2022-01-20 | グアンドン・ヘボ・ファーマシューティカル・カンパニー・リミテッド | スピロ３員環、スピロ５員環系ペプチドデホルミラーゼ阻害剤および抗菌と抗腫瘍におけるその使用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3282986A (en) * | 1960-10-06 | 1966-11-01 | Merck & Co Inc | N-acylated hydroxamic acids and derivatives thereof |
| WO1999039704A1 (en) * | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
| WO2002102790A1 (en) * | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | N-formyl hydroxylamine compounds as inhibitors of pdf |
-
2004
- 2004-03-29 TW TW093108548A patent/TW200427458A/zh unknown
- 2004-03-31 AR ARP040101079A patent/AR043804A1/es not_active Application Discontinuation
- 2004-03-31 PE PE2004000339A patent/PE20050392A1/es not_active Application Discontinuation
- 2004-04-01 MX MXPA05010610A patent/MXPA05010610A/es unknown
- 2004-04-01 CN CNA2004800078725A patent/CN1764450A/zh active Pending
- 2004-04-01 AU AU2004226815A patent/AU2004226815B2/en not_active Ceased
- 2004-04-01 SG SG200801365-8A patent/SG166681A1/en unknown
- 2004-04-01 MY MYPI20041200A patent/MY136854A/en unknown
- 2004-04-01 JP JP2006504952A patent/JP2006522054A/ja active Pending
- 2004-04-01 WO PCT/EP2004/003478 patent/WO2004087133A1/en not_active Ceased
- 2004-04-01 KR KR1020057018676A patent/KR20060002915A/ko not_active Ceased
- 2004-04-01 CL CL200400705A patent/CL2004000705A1/es unknown
- 2004-04-01 EP EP04725014A patent/EP1613305A1/en not_active Ceased
- 2004-04-01 RU RU2005133660/04A patent/RU2005133660A/ru not_active Application Discontinuation
- 2004-04-01 NZ NZ542432A patent/NZ542432A/en unknown
- 2004-04-01 CA CA002520682A patent/CA2520682A1/en not_active Abandoned
- 2004-04-01 US US10/550,631 patent/US20070135353A1/en not_active Abandoned
- 2004-04-01 BR BRPI0409009-8A patent/BRPI0409009A/pt not_active IP Right Cessation
-
2005
- 2005-09-07 ZA ZA200507179A patent/ZA200507179B/en unknown
- 2005-09-28 EC EC2005006043A patent/ECSP056043A/es unknown
- 2005-09-30 TN TNP2005000248A patent/TNSN05248A1/en unknown
- 2005-10-04 CO CO05100510A patent/CO5630028A2/es not_active Application Discontinuation
- 2005-10-11 MA MA28547A patent/MA27763A1/fr unknown
- 2005-10-27 IS IS8093A patent/IS8093A/is unknown
- 2005-11-01 NO NO20055097A patent/NO20055097L/no not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3282986A (en) * | 1960-10-06 | 1966-11-01 | Merck & Co Inc | N-acylated hydroxamic acids and derivatives thereof |
| WO1999039704A1 (en) * | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
| WO2002102790A1 (en) * | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | N-formyl hydroxylamine compounds as inhibitors of pdf |
Also Published As
| Publication number | Publication date |
|---|---|
| NO20055097L (no) | 2005-12-22 |
| CA2520682A1 (en) | 2004-10-14 |
| US20070135353A1 (en) | 2007-06-14 |
| RU2005133660A (ru) | 2006-06-10 |
| AU2004226815B2 (en) | 2007-07-19 |
| NZ542432A (en) | 2009-04-30 |
| PE20050392A1 (es) | 2005-06-19 |
| TNSN05248A1 (en) | 2007-06-11 |
| MXPA05010610A (es) | 2005-11-23 |
| BRPI0409009A (pt) | 2006-03-28 |
| IS8093A (is) | 2005-10-27 |
| AU2004226815A1 (en) | 2004-10-14 |
| CO5630028A2 (es) | 2006-04-28 |
| CL2004000705A1 (es) | 2005-01-14 |
| WO2004087133A1 (en) | 2004-10-14 |
| MA27763A1 (fr) | 2006-02-01 |
| MY136854A (en) | 2008-11-28 |
| ZA200507179B (en) | 2006-04-26 |
| NO20055097D0 (no) | 2005-11-01 |
| KR20060002915A (ko) | 2006-01-09 |
| ECSP056043A (es) | 2006-01-27 |
| JP2006522054A (ja) | 2006-09-28 |
| TW200427458A (en) | 2004-12-16 |
| EP1613305A1 (en) | 2006-01-11 |
| AR043804A1 (es) | 2005-08-10 |
| CN1764450A (zh) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| BRPI0412763A (pt) | formas anidras, hidratadas ou solvatadas de um composto, forma cristalina, composição farmacêutica, e, método para o tratamento ou a profilaxia de distúrbios | |
| NO20070606L (no) | Inhibitorer av IAP | |
| TW200640908A (en) | Chemical compounds | |
| MY138619A (en) | N-formyl hydroxylamine compounds | |
| NO20083207L (no) | Inhibitorer av IAP | |
| HUP0400446A2 (hu) | Azitromicin kristályformái | |
| GB0318447D0 (en) | Therapeutic agents | |
| ATE433981T1 (de) | Heterocyclische verbindungen | |
| AU2003291885A1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
| TW200504012A (en) | Ethynylproline derivatives | |
| NZ510369A (en) | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection | |
| MA27566A1 (fr) | Inhibiteurs de 4-oxo-1-(3-phenyle substitue -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4 | |
| NO20054476L (no) | Forbindelser for behandling av smerte | |
| NO20035791L (no) | Nye derivater av oksazolidinoner som antibakterielle midler | |
| IL173377A0 (en) | Compounds for the treatment of metabolic disorders | |
| NO20044548L (no) | Fremgangsmate for fremstilling av 6-alkaliden-penemderivater | |
| SI1511472T1 (sl) | Spojine uporabne pri zdravljenju antraksa in inhibiranju letalnega faktorja | |
| SG166681A1 (en) | Crystalline n-formyl hydroxylamine compounds | |
| NO331012B1 (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| NO20055750L (no) | Nye kjemiske forbindelser | |
| NO20081103L (no) | 9-Aminoklarbonylsubstituerte derivater av glycylcykliner | |
| ATE377017T1 (de) | Verbindungen, die faktor xa-aktiv t inhibieren | |
| MY139289A (en) | Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
| SE0302853D0 (sv) | Chemical compounds |